Mechanisms involved in alleviation of intestinal inflammation by bifidobacterium breve soluble factors.
about
Role of the gut microbiota in defining human healthProteinaceous Molecules Mediating Bifidobacterium-Host InteractionsTh17 Cells as Potential Probiotic Therapeutic Targets in Inflammatory Bowel DiseasesColonization of C57BL/6 Mice by a Potential Probiotic Bifidobacterium bifidum Strain under Germ-Free and Specific Pathogen-Free Conditions and during Experimental ColitisProbiotic-derived polyphosphate enhances the epithelial barrier function and maintains intestinal homeostasis through integrin-p38 MAPK pathwayUnderstanding gut microbiota in elderly's health will enable intervention through probiotics.Mechanistic Study of Utilization of Water-Insoluble Saccharomyces cerevisiae Glucans by Bifidobacterium breve Strain JCM1192.Bifidobacterium breve MCC-117 Induces Tolerance in Porcine Intestinal Epithelial Cells: Study of the Mechanisms Involved in the Immunoregulatory Effect.Microbial diversity in saliva of oral squamous cell carcinomaGut microbial diversity is reduced by the probiotic VSL#3 and correlates with decreased TNBS-induced colitis.Bifidobacteria-host interactions--an update on colonisation factors.Anti-inflammatory properties of Streptococcus salivarius, a commensal bacterium of the oral cavity and digestive tract.Disruption of NF-kappaB signalling by ancient microbial molecules: novel therapies of the future?Probiotics: progress toward novel therapies for intestinal diseases.Bifidobacterium longum alleviates dextran sulfate sodium-induced colitis by suppressing IL-17A response: involvement of intestinal epithelial costimulatory moleculesInhibition of the NF-kappaB pathway in human intestinal epithelial cells by commensal Streptococcus salivarius.Gut ecosystem: how microbes help us.Aging of the human metaorganism: the microbial counterpartHigh-Quality Draft Genome Sequence of Bifidobacterium longum E18, Isolated from a Healthy Adult.Gut microbiota and probiotics in modulation of epithelium and gut-associated lymphoid tissue function.Human intestinal microbiota: cross-talk with the host and its potential role in colorectal cancer.Microbes and microbial effector molecules in treatment of inflammatory disorders.The application of Ussing chambers for determining the impact of microbes and probiotics on intestinal ion transport.Quercetin and related polyphenols: new insights and implications for their bioactivity and bioavailability.Soluble bioactive microbial mediators regulate proteasomal degradation and autophagy to protect against inflammation-induced stress.Effects of phytochemicals on in vitro anti-inflammatory activity of Bifidobacterium adolescentis.Flavonols enhanced production of anti-inflammatory substance(s) by Bifidobacterium adolescentis: prebiotic actions of galangin, quercetin, and fisetin.The Gut Microbiota and Alzheimer's Disease.Efficacy of Bifidobacterium breve NCC2950 against DSS-induced colitis is dependent on bacterial preparation and timing of administration.Anti-inflammatory properties of intestinal Bifidobacterium strains isolated from healthy infants.Anti-inflammatory properties of dairy lactobacilli.A Bifidobacterium probiotic strain and its soluble factors alleviate chloride secretion by human intestinal epithelial cells.Selection of bifidobacteria based on adhesion and anti-inflammatory capacity in vitro for amelioration of murine colitis.Immune modulating capability of two exopolysaccharide-producing Bifidobacterium strains in a Wistar rat modelDual roles of endogenous platelet-activating factor acetylhydrolase in a murine model of necrotizing enterocolitis.Identification of NF-κB modulation capabilities within human intestinal commensal bacteria.Prebiotic Supplementation Following Ileocecal Resection in a Murine Model is Associated With a Loss of Microbial Diversity and Increased Inflammation.
P2860
Q24599062-933B36C9-9308-43F8-887B-F4BBB138121AQ26740603-BD55B681-951E-496F-9D5E-851287B988E3Q26784194-79C2ABD5-1C70-43D3-B04B-BB132054ADC8Q27314785-3647CA26-D193-4199-BDB5-AE0ADE4B311AQ28476547-C40BE83B-B39A-4B35-9D79-7A0782884019Q30487021-096574C4-8127-4632-AB1E-F879A0D12847Q31156251-157EC234-F1AA-489C-B3FA-533296BC285CQ33666179-928C9EBB-116C-4381-AEEB-2926ADF06020Q33785278-D2D8F3A3-CDB8-4FFA-8835-11685B86227AQ34192292-894F8A7B-CC3B-4C66-94D4-51B0509D1ADCQ34256838-397E10CB-087C-45CC-A2C5-F6F94A67E271Q34387493-1EB047A8-A85F-4B7E-9216-98A7124682A8Q34565823-7B757236-39B5-4885-9ECF-F03FEF9D189FQ34565839-56492375-3631-4AC1-854F-0EF969D2F097Q35047429-DD457FCE-CAEA-48D7-8178-24CAC3B89F00Q35080941-BE3B8550-6536-410B-AA09-372CC395B076Q35105266-3C8A18AB-4D4D-4371-9B20-0BE3C6AB6051Q35678151-327E8A75-4649-4301-BD66-02E0493FF7A6Q37405319-6A4D493E-5B3A-4BEC-80D2-A96CE1190432Q37642855-D1AFF6E0-7C06-48BC-8309-C8BA8C3138BCQ37793208-CE389449-8A47-4706-86E0-F0D23A1CC1DBQ37968291-B0C13176-86A8-476F-9D75-D774D5AAE088Q38132251-9C6E7543-7532-4998-BA05-55B09DE26D04Q38374202-D8540827-1E4F-4A21-88EF-E89C990081B7Q38752414-9912B767-7980-46BD-A424-85F2D178FF0DQ38905606-3F4F7D31-7E96-447D-9889-19BA74F69BF2Q39171816-111A3EB7-539C-445B-864E-D064A37A6777Q39217126-04EEE9E2-3257-4495-B63C-1E6CDDC3E14AQ39249472-59EC425A-6ECC-4E21-A910-A3C20BBDAB7AQ39450357-AD45FE74-BAA7-4D29-B776-2CF5AF6AC6BCQ39491174-C088598F-8922-4A2E-A3DC-BF42B2F88C56Q39778886-425CCB56-4FF2-46F9-B5B4-2A320BB481BBQ40328326-F5246D11-0C61-4045-99F5-E1DB510630A9Q40723316-ECB2B09E-830D-46EC-BC2F-92D1FE6AAE00Q41819448-9EBBE241-3D3C-4A7F-AE4E-C2152AFB85E9Q41907716-1AE92BFB-C138-46C3-91E9-1E137E51C04EQ49616226-85E3716C-2FA0-4637-96F3-0C6623770274
P2860
Mechanisms involved in alleviation of intestinal inflammation by bifidobacterium breve soluble factors.
description
2009 nî lūn-bûn
@nan
2009 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Mechanisms involved in allevia ...... cterium breve soluble factors.
@ast
Mechanisms involved in allevia ...... cterium breve soluble factors.
@en
type
label
Mechanisms involved in allevia ...... cterium breve soluble factors.
@ast
Mechanisms involved in allevia ...... cterium breve soluble factors.
@en
prefLabel
Mechanisms involved in allevia ...... cterium breve soluble factors.
@ast
Mechanisms involved in allevia ...... cterium breve soluble factors.
@en
P2093
P2860
P1433
P1476
Mechanisms involved in allevia ...... cterium breve soluble factors.
@en
P2093
Corinne Grangette
Corinne Lebreton
Elise Heuvelin
Martine Heyman
P2860
P356
10.1371/JOURNAL.PONE.0005184
P407
P577
2009-04-17T00:00:00Z